MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹925 Cr | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹925 Cr |
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹925 Cr | -9.29 | |
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,896.9 Cr | -0.7% | 5.4% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.7% |
5.4% |
0.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses